Department of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.
VA Portland Health Care System, Portland, Oregon.
Alcohol Clin Exp Res. 2020 May;44(5):1025-1036. doi: 10.1111/acer.14318. Epub 2020 Mar 27.
Chronic alcohol exposure can alter glucocorticoid receptor (GR) function in some brain areas that promotes escalated and compulsive-like alcohol intake. GR antagonism can prevent dependence-induced escalation in drinking, but very little is known about the role of GR in regulating high-risk nondependent alcohol intake. Here, we investigate the role of GR in regulating binge-like drinking and aversive responses to alcohol in the High Drinking in the Dark (HDID-1) mice, which have been selectively bred for high blood ethanol (EtOH) concentrations (BECs) in the Drinking in the Dark (DID) test, and in their founder line, the HS/NPT.
In separate experiments, male and female HDID-1 mice were administered one of several compounds that inhibited GR or its negative regulator, FKBP51 (mifepristone [12.5, 25, 50, 100 mg/kg], CORT113176 [20, 40, 80 mg/kg], and SAFit2 [10, 20, 40 mg/kg]) during a 2-day DID task. EtOH consumption and BECs were measured. EtOH conditioned taste and place aversion (CTA and CPA, respectively) were measured in separate HDID-1 mice after mifepristone administration to assess GR's role in regulating the conditioned aversive effects of EtOH. Lastly, HS/NPT mice were administered CORT113176 during DID to assess whether dissimilar effects from those of HDID-1 would be observed, which could suggest that selective breeding had altered sensitivity to the effects of GR antagonism on binge-like drinking.
GR antagonism (with both mifepristone and CORT113176) selectively reduced binge-like EtOH intake and BECs in the HDID-1 mice, while inhibition of FKBP51 did not alter intake or BECs. In contrast, GR antagonism had no effect on EtOH intake or BECs in the HS/NPT mice. Although HDID-1 mice exhibit attenuated EtOH CTA, mifepristone administration did not enhance the aversive effects of EtOH in either a CTA or CPA task.
These data suggest that the selection process increased sensitivity to GR antagonism on EtOH intake in the HDID-1 mice, and support a role for the GR as a genetic risk factor for high-risk alcohol intake.
慢性酒精暴露会改变某些大脑区域的糖皮质激素受体 (GR) 功能,从而促进酒精摄入的增加和强迫性。GR 拮抗作用可以防止依赖引起的饮酒增加,但对于 GR 在调节高危非依赖饮酒中的作用知之甚少。在这里,我们研究了 GR 在调节高饮酒量黑暗 (HDID-1) 小鼠 binge 样饮酒和对酒精的厌恶反应中的作用,这些小鼠已被选择性繁殖用于血液乙醇 (EtOH) 浓度 (BEC) 高的饮酒黑暗 (DID) 测试,以及其创始线 HS/NPT。
在单独的实验中,雄性和雌性 HDID-1 小鼠在 2 天的 DID 任务期间给予几种抑制 GR 或其负调节剂 FKBP51 的化合物之一(米非司酮 [12.5、25、50、100mg/kg]、CORT113176 [20、40、80mg/kg] 和 SAFit2 [10、20、40mg/kg])。测量 EtOH 消耗和 BEC。在米非司酮给药后,在单独的 HDID-1 小鼠中测量 EtOH 条件味觉和位置厌恶 (CTA 和 CPA,分别),以评估 GR 在调节 EtOH 的条件厌恶效应中的作用。最后,在 DID 期间给 HS/NPT 小鼠施用 CORT113176,以评估是否会观察到与 HDID-1 不同的作用,这可能表明选择性繁殖改变了对 GR 拮抗作用对 binge 样饮酒的敏感性。
GR 拮抗作用(米非司酮和 CORT113176 均)选择性地降低了 HDID-1 小鼠的 binge 样 EtOH 摄入和 BEC,而 FKBP51 的抑制作用并未改变摄入或 BEC。相比之下,GR 拮抗作用对 HS/NPT 小鼠的 EtOH 摄入或 BEC 没有影响。尽管 HDID-1 小鼠表现出 EtOH CTA 减弱,但米非司酮给药并未增强 EtOH 在 CTA 或 CPA 任务中的厌恶效应。
这些数据表明,选择过程增加了 HDID-1 小鼠对 EtOH 摄入的 GR 拮抗作用的敏感性,并支持 GR 作为高危酒精摄入遗传风险因素的作用。